1-3 of 3
ebvp protocol
Close
Sort by
Journal Articles

Pharmacogenetic Study in Hodgkin’s Lymphomas, Impact of UGT1A1 on Prognosis.

Vincent Ribrag, MD, Serge Koscielny, phD, Olivier Casasnovas, MD, Cecile Cazeneuve, MD, phD, Pauline Brice, MD, Franck Morschhauser, MD, Jean Gabarre, MD, Marine Divine, MD, Laurent Voillat, MD, Apasia Stamatoullas, MD, Gilbert Lenoir, phD, Gilles Andre Salles, MD, phD
Journal: Blood
Blood (2006) 108 (11): 2266.
https://doi.org/10.1182/blood.V108.11.2266.2266
Published: 2006
Journal Articles

Hodgkin’s Disease and HIV Infection (HD-HIV) in Pre- and Post-HAART Era: The GICAT (Italian Cooperative Group on AIDS and Tumors) Experience in 139 Patients.

Umberto Tirelli, MD, Emanuela Vaccher, MD, Giuseppe Rossi, MD, Clara Schiantarelli, MD, Marco Fasan, MD, Michele Spina, MD
Journal: Blood
Blood (2005) 106 (11): 1437.
https://doi.org/10.1182/blood.V106.11.1437.1437
Published: 2005
Journal Articles

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

Houchingue Eghbali, MD, Pauline Brice, MD, Geert-Yan Creemers, MD, Marinus van Marwijk Kooij, MD, Patrice Carde, MD, Mars B. Van’t Veer, MD, Elli Lugtenburg, MD, Anne Sonet, MD, Catherine Sebban, MD, Michel Blanc, MD, John M. Raemaekers, MD, Laurent Voillat, MD, Chantal Rieux, Ed M. Noordijk, MD, Michel Henry-Amar, MD
Journal: Blood
Blood (2005) 106 (11): 814.
https://doi.org/10.1182/blood.V106.11.814.814
Published: 2005